Hamdi, Amir <br/><br/>
Donor cell-derived myelodysplastic syndrome with ring chromosome 7 after allogeneic hematopoietic stem cell transplant in 2 patients with lymphomas as primary disease.  [electronic resource] 

 -  Clinical lymphoma, myeloma & leukemia  Oct 2014 
 - e151-5 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>2152-2669 
<br/><br/><label>Standard No.: </label>10.1016/j.clml.2014.04.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Allografts<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Biomarkers, Tumor<br/>Bone Marrow--pathology<br/>Cell Transformation, Neoplastic--genetics<br/>Chromosome Deletion<br/>Chromosomes, Human, Pair 7--genetics<br/>Cyclophosphamide--administration & dosage<br/>Disease Progression<br/>Female<br/>Gene Deletion<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Leukemia, Myeloid, Acute--etiology<br/>Living Donors<br/>Lymphoma, Follicular--drug therapy<br/>Lymphoma, Mantle-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--etiology<br/>Neoplasms, Second Primary--etiology<br/>Peripheral Blood Stem Cell Transplantation<br/>Proto-Oncogene Proteins c-ets--deficiency<br/>Repressor Proteins--deficiency<br/>Ring Chromosomes<br/>Rituximab<br/>Transplantation Chimera--genetics<br/>Vidarabine--administration & dosage<br/>ETS Translocation Variant 6 Protein